Leucocare AG Martinsried/München News & Veranstaltungen

Press Releases

Sep. 2018

  LEUKOCARE presenting at 12th Vaccine Congress in Budapest, Hungary

(more...)
Sep. 2018

  LEUKOCARE and Xellia Pharmaceuticals partner to discover innovative formulations for the development of value-added anti-infective therapies

(more...)
Jul. 2018

 LEUKOCARE completes formation of second tier of management

(more...)
Jun. 2018

 LEUKOCARE grants a license on its SPS® formulation technology platform to Laboratorios Liomont for development and commercialization of a biosimilar

(more...)
Back

Publications

Amino acid-based advanced liquid formulation development for highly concentrated therapeutic antibodies balances physical and chemical stability and low viscosity

Biotechnol. J. 2018, 13, 1700523

SCHOLZ M. ET AL.:Amino acid-based advanced liquid formulation development for highly concentrated therapeutic antibodies balances physical and chemical stability and low viscosity

(more...)

PloS ONE

2014 December, PLoS ONE 9(12): e115940. doi:10.1371/journal.pone.

WINDOLF C.D. ET AL.:Lysostaphin-Coated Titan-Implants Preventing Localized Osteitis by Staphyloccus aureus in a Mouse Model (more...)

Human Vaccines & Immunotherapeutics

2014 July; Vol. 10, Issue 10, Meeting Report

DERWAND R.: Annual World Vaccine Congress 2014: A re-evaluation of the value proposition for increasing vaccine thermostability (more...)

Vaccine

2014 April; Vol. 32, Issue 19

SCHERLIESS R. ET AL.: Induction of protective immunity against H1N1 influenza A(H1N1)pdm09 with spray-dried and electron-beam sterilised vaccines in non-human primates

(more...)

Back

Next Events

Meet us at the following events

Meet us at the Freeze Drying Conference

Meet us at the Freeze Drying Conference
September 14th - September 21th, 2018
Garmisch-Patenkirchen, Germany (more...)

Back